Surgical salvage of cancer of the oropharynx after chemoradiation

Current Oncology Reports

Volumn 11, Issue 2, 2009, Pages 151-155

  Bumpous, Jeffrey M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PROTOCOL; EAR NOSE THROAT SURGERY; HUMAN; OROPHARYNX CANCER; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT RESPONSE; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; QUALITY OF LIFE; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 60349109660     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0022-6     Document Type: Review

References (16)

1. Chen AY, Schrag N, Hao Y, et al.: Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007, 117:16-21.
2. Been MJ, Watkins J, Manz RM, et al.: Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy. Laryngoscope 2008, 118:1377-1382.
3. Cmelak AJ, Li S, Goldwasser MA, et al.: Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: Results of the Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 2007, 25:3971-3977.
4. Huang K, Xia P, Chuang C, et al.: Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: The University of California-San Francisco Experience. Cancer 2008, 113:497-507.
5. Kumar B, Cordell KG, Lee JS, et al.: EGFR, p16, Bcl-xl and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008, 26:3128-3137.
6. Hafkamp H, Manni J, Hasesevoets A, et al.: Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008, 122:2656-2664.
7. Worden F, Kumar B, Lee JS, et al.: Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV 16 copy number. J Clin Oncol 2008, 26:3138-3146.
8. Cohen M, Basha S, Reichenbach D, et al.: Increased viral load correlates with improved survival in HPV-16 associated tonsil carcinoma patients. Acta Otolaryngol 2008, 128:583-589.
9. McRackan T, Watkins J, Herrin A, et al.: Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope 2008, 118:1180-1185.
10. Schuller D, Ozer E, Agrawal A, et al.: Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx. Arch Otolaryngol Head Neck Surg 2007, 133:320-326.
11. Kim S, Roh J, Kim M, et al.: Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 2007, 48:752-757.
12. Perie S, Hugentobler A, Susini B, et al.: Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2007, 137:647-653.
13. Enomoto K, Inohara H, Higuchi I, et al.: Prognostic value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy. Mol Imaging Biol 2008, 10:224-229.
14. Gurney T, Eisele D, Orloff L, et al.: Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma. Otolaryngol Head Neck Surg 2008, 139:262-267.
15. Agra I, Carvalho A, Ulbrich F, et al.: Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006, 28:107-113.
16. Chedid H, Franzi S: Assessment of demographics factors and clinical staging in patients submitted to salvage surgery for oropharyngeal squamous cell carcinoma. Braz Otorhinolaringol 2008, 74:532-536.